Dose Individualization of Pemetrexed - IMPROVE-I

NCT03656549 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Mesothelioma

Interventions

DRUG: Pemetrexed + oral folinic acid rescue

Sponsor

Radboud University Medical Center

Collaborators

[object Object]